Cellular characteristics and clinical assessment of breast cancer using F-18 FDG-PET
Cellular characteristics and clinical assessment of breast cancer using F-18 FDG-PET
批准号:
17591304
负责人:
ISHIBASHI Masatoshi
金额:
$1.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One hundred eighteen female patients (age range 28-91 years) with 122 lesions suspected of having breast cancer underwent fluorine-18 fluorodeoxyglucose (^<18>F-FDG) PET for preoperative staging. After the whole-body image was acquired, prone breast PET imaging was performed. The findings from both images were compared with the histopathologic results. Sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV), and accuracy were used to compare the diagnostic accuracy of prone breast PET images with that of whole-body PET images. Sensitivity, specificity, PPV, NPV, and accuracy of whole-body PET images were 83%, 50%, 97%, 17%, and 80%, and for prone breast PET images were 95%, 50%, 96%, 43%, and 93%. Ten of 114 breast cancerous lesions (8.8%) were detected on prone breast PET images alone. There was statistical difference between the sensitivity, accuracy, and NPV of prone breast PET images and, those of whole-body PET images (P < 0.0001 for sensitivity and accuracy, and P < 0.0009 for NPV). In conclusion, our data regarding the 122 lesions suspected of breast cancer with regard to the usefulness of prone breast PET imaging indicate that prone breast PET images are effective in detecting breast cancer.With respect to cell proliferation in breast cancer, we evaluated the relationship between ERK MAPK and SUVmax obtained by FDG-PET. Unfortunately, there was no correlation between ERK MAPK obtained by immunohistopathology and SUVmax. Our resultant data addressed that cell proliferation in breast cancer is need to choose the future course in the FDG-PET study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
17b-Estradiol induces down-regulation of Cap43/NDRG1/Drg-l, a putative differentiation-related ,metastasis suppressor gene, in human breast cancer cells.
17b-Estradiol 诱导人类乳腺癌细胞中 Cap43/NDRG1/Drg-1(一种假定的分化相关转移抑制基因)的下调。
DOI:
--
发表时间:
2006
期刊:
Clin Cancer Res 12
影响因子:
--
作者:
[Fotovati A, Fujii T, et. al.]
通讯作者:
et. al.
Expression of ErbB2/HER2 and Expression of ErbB2/HER2 and Y-box binding protein-i in human breast cancers
人乳腺癌中 ErbB2/HER2 的表达以及 ErbB2/HER2 和 Y-box 结合蛋白-i 的表达
DOI:
--
发表时间:
2008
期刊:
Cancer Res (in press)
影响因子:
--
作者:
[Fujii T, Yamana H, et. al.]
通讯作者:
et. al.
Improved breast cancer detection of prone breast FDG-PET ml 18 patients.
改进了对 18 名患者俯卧乳腺 FDG-PET ml 的乳腺癌检测。
DOI:
--
发表时间:
2008
期刊:
Nuci Med Commun (in press)
影响因子:
--
作者:
[Kaida H, Ishibashi M, et. al.]
通讯作者:
et. al.
Evaluation of FDG-PET in paatients with bxaest cancer using the 〓 device
使用〓装置对bxaest癌症患者进行FDG-PET评估
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Kaida H, Whibashi M, et. al.]
通讯作者:
et. al.
Improved breast cancer detection of prone breast FDG-PET in 118 patients
俯卧乳腺 FDG-PET 改进了 118 名患者的乳腺癌检测
DOI:
--
发表时间:
2008
期刊:
Nucl Med Commun
影响因子:
1.5
作者:
[Kaida H, Ishibashi M, et. al.]
通讯作者:
et. al.
共 9 条
The investigation of both FDG uptake mechanism and predicton prognosis using PET/CT in pancreatic cancer patients
-
批准号:23591807
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
Molecular pathological evaluation of therapeutic effect using PET/CT in patients with esophageal cancer
-
批准号:20591465
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
The analysis and clinical application cellular characteristics of lung carcinoma or thyroid cancer using radionuclide tracer
-
批准号:12670914
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:2000
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
海外基金